[Combination therapy for the treatment of pulmonary arterial hypertension].
Kähler
C M
CM
Pneumologie/USPH Innsbruck-Universitätsklinik für Innere Medizin I, Medizinische Universität Innsbruck. C.M.Kaehler@i-med.ac.at
D000280:Administration, Inhalation; D000465:Algorithms; D065128:Endothelin Receptor Antagonists; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000628:therapy*; D016285:Iloprost / Q000008:administration & dosage / Q000627:therapeutic use; D007275:Injections, Intravenous; D016040:Lung Transplantation; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use
D065128:Endothelin Receptor Antagonists; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D016285:Iloprost